APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phosphoinositide 3-Kinase (PI3K) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025185 pages

Choose your research edition.

Industry ResearchPhosphoinositide 3-Kinase (PI3K) Inhibitors Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Phosphoinositide 3-Kinase (PI3K) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Phosphoinositide 3-Kinase (PI3K) Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Phosphoinositide 3-Kinase (PI3K) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phosphoinositide 3-Kinase (PI3K) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phosphoinositide 3-Kinase (PI3K) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Phosphoinositide 3-Kinase (PI3K) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phosphoinositide 3-Kinase (PI3K) Inhibitors include Novartis AG, Bayer AG, Verastem Inc., TG Therapeutics Inc. and Gilead Sciences Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phosphoinositide 3-Kinase (PI3K) Inhibitors and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phosphoinositide 3-Kinase (PI3K) Inhibitors revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Phosphoinositide 3-Kinase (PI3K) Inhibitors market size, projected growth trends, production technologies, key applications, and end-use industries.

Phosphoinositide 3-Kinase (PI3K) Inhibitors Segment by Company

Novartis AG

Bayer AG

Verastem Inc.

TG Therapeutics Inc.

Gilead Sciences Inc.

Phosphoinositide 3-Kinase (PI3K) Inhibitors Segment by Type

CLL - Chronic Iymphocytic Ieukemia

FL - Follicular Iymphoma

Other Indications

Phosphoinositide 3-Kinase (PI3K) Inhibitors Segment by Application

Clinic

hospital

Research Institutes and Research Institutions

Other

Phosphoinositide 3-Kinase (PI3K) Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phosphoinositide 3-Kinase (PI3K) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phosphoinositide 3-Kinase (PI3K) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Phosphoinositide 3-Kinase (PI3K) Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phosphoinositide 3-Kinase (PI3K) Inhibitors industry.

Chapter 3: Detailed analysis of Phosphoinositide 3-Kinase (PI3K) Inhibitors companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phosphoinositide 3-Kinase (PI3K) Inhibitorsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of CLL - Chronic Iymphocytic Ieukemia Table 3. Key Players of FL - Follicular Iymphoma Table 4. Key Players of Other Indications Table 4. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinic Table 6. Key Players of hospital Table 7. Key Players of Research Institutes and Research Institutions Table 8. Key Players of Other Table 9. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Region (2021-2026) Table 12. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Region (2027-2032) Table 14. Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Trends Table 15. Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Drivers Table 16. Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Opportunities and Challenges Table 17. Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Restraints Table 18. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Company (2021-2026) Table 20. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Company Head Office and Area Served Table 22. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Company, Product Type & Application Table 23. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2021-2026) Table 30. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2027-2032) Table 31. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Application (2021-2026) Table 35. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Application (2027-2032) Table 36. Novartis AG Company Information Table 37. Novartis AG Business Overview Table 38. Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio Table 40. Novartis AG Recent Development Table 41. Bayer AG Company Information Table 42. Bayer AG Business Overview Table 43. Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio Table 45. Bayer AG Recent Development Table 46. Verastem Inc. Company Information Table 47. Verastem Inc. Business Overview Table 48. Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio Table 50. Verastem Inc. Recent Development Table 51. TG Therapeutics Inc. Company Information Table 52. TG Therapeutics Inc. Business Overview Table 53. TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio Table 55. TG Therapeutics Inc. Recent Development Table 56. Gilead Sciences Inc. Company Information Table 57. Gilead Sciences Inc. Business Overview Table 58. Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio Table 60. Gilead Sciences Inc. Recent Development Table 61. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 62. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 63. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 64. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 65. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 66. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021-2026) Table 67. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2027-2032) Table 68. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 69. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 70. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 71. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 72. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021-2026) Table 74. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2027-2032) Table 75. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 76. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 77. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 78. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 79. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 80. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 81. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 82. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021-2026) Table 85. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2027-2032) Table 86. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 87. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032) & (US$ Million) Table 88. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 89. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032) & (US$ Million) Table 90. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021-2026) Table 92. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2027-2032) Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Image Figure 2. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type: 2025 VS 2032 Figure 4. CLL - Chronic Iymphocytic Ieukemia Image Figure 5. FL - Follicular Iymphoma Image Figure 6. Other Indications Image Figure 7. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application: 2025 VS 2032 Figure 9. Clinic Image Figure 10. hospital Image Figure 11. Research Institutes and Research Institutions Image Figure 12. Other Image Figure 13. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 15. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Phosphoinositide 3-Kinase (PI3K) Inhibitors Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2021-2032) Figure 22. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Application (2021-2032) Figure 24. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 25. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032) Figure 26. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032) Figure 27. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2021-2032) Figure 28. United States Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 29. Canada Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 31. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 32. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032) Figure 33. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032) Figure 34. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2021-2032) Figure 35. Germany Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 36. France Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 38. Italy Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 39. Russia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 41. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 42. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032) Figure 43. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032) Figure 44. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 45. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032) Figure 46. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032) Figure 47. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2021-2032) Figure 48. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 52. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 53. Australia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2021-2032) Figure 58. Brazil Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 63. UAE Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 65. Chile Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • CLL - Chronic Iymphocytic Ieukemia
  • FL - Follicular Iymphoma
  • Other Indications
Applications
  • Clinic
  • hospital
  • Research Institutes and Research Institutions
  • Other
Companies covered
  • Novartis AG
  • Bayer AG
  • Verastem Inc.
  • TG Therapeutics Inc.
  • Gilead Sciences Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 CLL - Chronic Iymphocytic Ieukemia
  5. 1.2.3 FL - Follicular Iymphoma
  6. 1.2.4 Other Indications
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Clinic
  10. 1.3.3 hospital
  11. 1.3.4 Research Institutes and Research Institutions
  12. 1.3.5 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Trends by Region
  15. 1.5.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2021-2026)
  17. 1.5.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Dynamics
  1. 2.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Trends
  2. 2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Drivers
  3. 2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Opportunities and Challenges
  4. 2.4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Company (2021-2026)
  2. 3.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Company Head office and Area Served
  4. 3.4 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Company, Product Type & Application
  5. 3.5 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Phosphoinositide 3-Kinase (PI3K) Inhibitors Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Phosphoinositide 3-Kinase (PI3K) Inhibitors Tier 1, Tier 2, and Tier 3
4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market by Type
  1. 4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2032)
  3. 4.3 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Share by Type (2021-2032)
5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market by Application
  1. 5.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2032)
  3. 5.3 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Bayer AG
  8. 6.2.1 Bayer AG Company Information
  9. 6.2.2 Bayer AG Business Overview
  10. 6.2.3 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio
  12. 6.2.5 Bayer AG Recent Developments
  13. 6.3 Verastem Inc.
  14. 6.3.1 Verastem Inc. Company Information
  15. 6.3.2 Verastem Inc. Business Overview
  16. 6.3.3 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio
  18. 6.3.5 Verastem Inc. Recent Developments
  19. 6.4 TG Therapeutics Inc.
  20. 6.4.1 TG Therapeutics Inc. Company Information
  21. 6.4.2 TG Therapeutics Inc. Business Overview
  22. 6.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio
  24. 6.4.5 TG Therapeutics Inc. Recent Developments
  25. 6.5 Gilead Sciences Inc.
  26. 6.5.1 Gilead Sciences Inc. Company Information
  27. 6.5.2 Gilead Sciences Inc. Business Overview
  28. 6.5.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Portfolio
  30. 6.5.5 Gilead Sciences Inc. Recent Developments
7 North America
  1. 7.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032)
  2. 7.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
  3. 7.2.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026)
  4. 7.2.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032)
  5. 7.2.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032)
  6. 7.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
  7. 7.3.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026)
  8. 7.3.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032)
  9. 7.3.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032)
  10. 7.4 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
  11. 7.4.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021-2026)
  13. 7.4.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2027-2032)
  14. 7.4.4 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032)
  2. 8.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
  3. 8.2.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026)
  4. 8.2.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032)
  5. 8.2.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032)
  6. 8.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
  7. 8.3.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026)
  8. 8.3.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032)
  9. 8.3.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032)
  10. 8.4 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
  11. 8.4.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021-2026)
  13. 8.4.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2027-2032)
  14. 8.4.4 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032)
  2. 9.2 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
  3. 9.2.1 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026)
  4. 9.2.2 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032)
  5. 9.2.3 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032)
  6. 9.3 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
  7. 9.3.1 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026)
  8. 9.3.2 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032)
  9. 9.3.3 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032)
  2. 10.2 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
  3. 10.2.1 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026)
  4. 10.2.2 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032)
  5. 10.2.3 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032)
  6. 10.3 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
  7. 10.3.1 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026)
  8. 10.3.2 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032)
  9. 10.3.3 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032)
  10. 10.4 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
  11. 10.4.1 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021-2026)
  13. 10.4.3 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2027-2032)
  14. 10.4.4 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst